2024
External Disruption of Ocular Development in Utero
Kim H, Sarrafpour S, Teng C, Liu J. External Disruption of Ocular Development in Utero. The Yale Journal Of Biology And Medicine 2024, 97: 41-48. PMID: 38559457, PMCID: PMC10964818, DOI: 10.59249/rrmm8911.Peer-Reviewed Original ResearchConceptsOcular developmentOcular embryologyEnglish-language articlesIntrauterine infectionMaternal nutritionClinical significanceGenetic signaling pathwaysWeb of ScienceAnimal modelsHormonal factorsHuman studiesMultifactorial naturePregnancySignaling pathwayGoogle ScholarReviewIntrauterineEmbryologyLimited resourcesGestationUteroPathophysiologyFactorsInfectionPubMed
2023
Acute Pain Management Protocol for Ophthalmic Procedures
Dhodapkar R, Jin A, Liu J. Acute Pain Management Protocol for Ophthalmic Procedures. 2023, 291-311. DOI: 10.1007/978-3-031-21291-8_18.ChaptersMotor nerve blockNerve blockOphthalmic proceduresPost-procedural painPain management protocolPostoperative painMaxillary divisionRetrobulbar injectionCardiac injuryTrigeminal nerveFacial nerveExtraocular musclesLocal anestheticsTenon's blockOculoplastic proceduresTrigeminovagal reflexGold standardPainAnesthesiaNerveManagement protocolExtra careOculocardiacBradycardiaAkinesia
2022
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2022, 2541-2560. DOI: 10.1007/978-3-030-42634-7_183.Peer-Reviewed Original ResearchPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroids
2020
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2020, 1-20. DOI: 10.1007/978-3-319-90495-5_183-1.ChaptersPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroidsHerbal Medicines in Glaucoma Treatment.
Ige M, Liu J. Herbal Medicines in Glaucoma Treatment. The Yale Journal Of Biology And Medicine 2020, 93: 347-353. PMID: 32607093, PMCID: PMC7309662.Peer-Reviewed Original ResearchConceptsCourse of glaucomaIntraocular pressureGlaucoma patientsGlaucoma treatmentRetinal ganglion cell deathHerbal medicineMedical marijuanaGanglion cell deathStandard therapeutic agentsSignificant adverse effectsCurrent standardGinkgo bilobaSurgical therapyGlaucoma managementIrreversible blindnessGlaucomaAlternative medicineLarger studyHerbal remediesTherapeutic agentsAddictive potentialAdverse effectsLonger durationPatientsShort duration
2019
Seven- and eight-year trends in resident and fellow glaucoma surgical experience
Chadha N, Warren JL, Liu J, Tsai JC, Teng CC. Seven- and eight-year trends in resident and fellow glaucoma surgical experience. Clinical Ophthalmology 2019, 13: 303-309. PMID: 30804662, PMCID: PMC6371949, DOI: 10.2147/opth.s185529.Peer-Reviewed Original ResearchMicroinvasive glaucoma surgerySurgical experienceGDI surgeryGlaucoma drainage implant surgeryPrimary filtering surgeryDrainage implant surgeryFellow case logsEight-year trendsTrabeculectomy surgeryGlaucoma surgeryFiltering surgeryGlaucoma casesTrainee surgical experienceImplant surgeryFellow casesSurgeryResident casesCase logsEndocyclophotocoagulationUS residentsAccreditation CouncilConcurrent increaseYearsYear trendsResidents
2018
Educational and Scholarly Opportunities for Medical Students and Residents in Professional Ophthalmology Organizations.
Yang A, Zhang X, Liu J, Chow J, Adelman R, Forster S. Educational and Scholarly Opportunities for Medical Students and Residents in Professional Ophthalmology Organizations. JAMA Ophthalmology 2018, 136: 1417-1419. PMID: 30326048, PMCID: PMC6594420, DOI: 10.1001/jamaophthalmol.2018.3963.Peer-Reviewed Original ResearchDelayed cystoid macular oedema after uncomplicated laser peripheral iridotomy
Yang AY, Kempton J, Liu J. Delayed cystoid macular oedema after uncomplicated laser peripheral iridotomy. Clinical And Experimental Ophthalmology 2018, 46: 823-824. PMID: 29468783, DOI: 10.1111/ceo.13180.Peer-Reviewed Original ResearchSequential cataract surgeries in a patient with a left ventricular assist device (LVAD)
Yang A, Liu J. Sequential cataract surgeries in a patient with a left ventricular assist device (LVAD). BMJ Case Reports 2018, 2018: bcr-2018-224238. PMID: 29549136, PMCID: PMC5878276, DOI: 10.1136/bcr-2018-224238.Peer-Reviewed Original ResearchConceptsLeft ventricular assist deviceSequential cataract surgeryVentricular assist deviceQuality of lifeCataract surgeryElective surgeryAssist deviceNon-cardiac elective surgeryPopulation of patientsCardiology evaluationDisease courseHeart failureIntravenous sedationLVAD supportVisual acuityIntraoperative monitoringPoor visionCommon causeHigh riskPatientsSurgeryLVAD deviceSignificant improvementPotential benefitsSedationImproving Glaucoma Surgical Outcomes with Adjunct Tools.
J Lu L, Hall L, Liu J. Improving Glaucoma Surgical Outcomes with Adjunct Tools. Journal Of Current Glaucoma Practice 2018, 12: 19-28. PMID: 29861578, PMCID: PMC5981089, DOI: 10.5005/jp-journals-10028-1239.Peer-Reviewed Original Research
2017
Irreversible Blindness Following Periocular Autologous Platelet-Rich Plasma Skin Rejuvenation Treatment
Kalyam K, Kavoussi SC, Ehrlich M, Teng CC, Chadha N, Khodadadeh S, Liu J. Irreversible Blindness Following Periocular Autologous Platelet-Rich Plasma Skin Rejuvenation Treatment. Ophthalmic Plastic And Reconstructive Surgery 2017, 33: s12-s16. PMID: 27015236, DOI: 10.1097/iop.0000000000000680.Peer-Reviewed Original ResearchConceptsAutologous platelet-rich plasma therapyPlatelet-rich plasma injectionPlatelet-rich plasma therapyOptic nerve infarctionAcute visual lossOccipital lobe infarctionOphthalmic artery occlusionNerve infarctionFundus examArtery occlusionExtensive ischemiaSkin necrosisSkin rejuvenation treatmentVascular etiologyVisual lossMuscle ischemiaOcular motilityRight eyePlasma therapyIrreversible blindnessGlabellar regionIschemiaInfarctionFirst casePlasma injectionNovel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.
Lu LJ, Tsai JC, Liu J. Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma. The Yale Journal Of Biology And Medicine 2017, 90: 111-118. PMID: 28356898, PMCID: PMC5369028.Peer-Reviewed Original ResearchConceptsPrimary open-angle glaucomaOpen-angle glaucomaIntraocular pressureProstaglandin analoguesDrug-related side effectsCurrent medical treatment optionsLowering of IOPTarget intraocular pressureMedical treatment optionsVisual field lossAlpha-adrenergic agonistsNew pharmacologic optionsLower intraocular pressureMultiple daily administrationBeta-adrenergic antagonistsAdenosine receptor agonistsLow patient complianceAqueous humor outflowRho-kinase inhibitorTrabecular meshwork outflow pathwaysLatanoprostene bunodPharmacologic optionsPharmacologic treatmentTopical medicationsDaily administrationNovel therapeutics for Stargardt disease
Lu LJ, Liu J, Adelman RA. Novel therapeutics for Stargardt disease. Graefe's Archive For Clinical And Experimental Ophthalmology 2017, 255: 1057-1062. PMID: 28285324, DOI: 10.1007/s00417-017-3619-8.Peer-Reviewed Original ResearchConceptsStargardt diseaseVision lossABCA4 geneStem cell transplantationSevere vision lossPromising treatment candidateNovel therapeutic strategiesRetinal pigment epitheliumStem cell therapyVisual acuityStandard treatmentMacular degenerationTreatment candidatesHESC-RPE cellsStargardt patientsTherapeutic strategiesPharmacological agentsPigment epitheliumMacular dystrophyNovel therapeuticsPatientsDiseaseVisual cyclePrevalent formSecond decadeEpigenetics and Signaling Pathways in Glaucoma
Gauthier AC, Liu J. Epigenetics and Signaling Pathways in Glaucoma. BioMed Research International 2017, 2017: 5712341. PMID: 28210622, PMCID: PMC5292191, DOI: 10.1155/2017/5712341.Peer-Reviewed Original ResearchConceptsPotential new therapeutic targetGeneration of fibrosisNovel therapeutic agentsNew therapeutic targetsAqueous humor drainageProapoptotic gene expressionRetinal neuronsIrreversible blindnessCommon causeHuman trialsTherapeutic targetAnimal modelsTrabecular meshworkTherapeutic agentsNeurodegenerative diseasesProsurvival factorBcl-2Rho-kinaseGlaucomaSignaling pathwaysPathway membersMAP kinaseGene expressionPathwayPreliminary success
2016
Applications of Scheimpflug Imaging in Glaucoma Management: Current and Potential Applications
Nguyen AT, Liu T, Liu J. Applications of Scheimpflug Imaging in Glaucoma Management: Current and Potential Applications. Journal Of Ophthalmology 2016, 2016: 3062381. PMID: 28044101, PMCID: PMC5164893, DOI: 10.1155/2016/3062381.Peer-Reviewed Original ResearchEpigenetics and Common Ophthalmic Diseases.
Li W, Liu J, Galvin JA. Epigenetics and Common Ophthalmic Diseases. The Yale Journal Of Biology And Medicine 2016, 89: 597-600. PMID: 28018148, PMCID: PMC5168835.Peer-Reviewed Original ResearchHuman Microbiota and Ophthalmic Disease.
Lu LJ, Liu J. Human Microbiota and Ophthalmic Disease. The Yale Journal Of Biology And Medicine 2016, 89: 325-330. PMID: 27698616, PMCID: PMC5045141.Peer-Reviewed Original ResearchThe Application of a Contact Lens Sensor in Detecting 24‐Hour Intraocular Pressure‐Related Patterns
Xu SC, Gauthier AC, Liu J. The Application of a Contact Lens Sensor in Detecting 24‐Hour Intraocular Pressure‐Related Patterns. Journal Of Ophthalmology 2016, 2016: 4727423. PMID: 27525110, PMCID: PMC4976175, DOI: 10.1155/2016/4727423.Peer-Reviewed Original ResearchContact lens sensorDisease progressionPrimary angle-closure glaucomaPrimary open-angle glaucomaCurrent glaucoma managementIOP-lowering interventionsSingle IOP measurementDisease statesThyroid eye diseaseAngle-closure glaucomaNormal-tension glaucomaOpen-angle glaucomaVisual field progressionIntraocular pressure fluctuationCause of blindnessOcular hypertensionClinic hoursClinical variablesGlaucoma managementField progressionDisease advancementEye diseaseIOP measurementsGlaucomaIOPTrends in ophthalmology resident surgical experience from 2009 to 2015
Chadha N, Liu J, Maslin JS, Teng CC. Trends in ophthalmology resident surgical experience from 2009 to 2015. Clinical Ophthalmology 2016, Volume 10: 1205-1208. PMID: 27418803, PMCID: PMC4935003, DOI: 10.2147/opth.s106293.Peer-Reviewed Original ResearchResident surgical experienceSurgical experienceCataract surgeryPhacoemulsification cataract surgerySurgical case logsArea of cataractShunt surgeryResident experiencePrimary surgeonRetinal photocoagulationDatabase studySurgical casesSurgerySurgical training programsOphthalmology residentsGlaucomaCase logsCataractTherapeutic developmentRetinaPediatricsTraumaAccreditation CouncilCorneaTraining programRisk factors for visual impairment associated with corneal diseases in southern China
Xu SC, Chow J, Liu J, Li L, Maslin JS, Chadha N, Chen B, Teng CC. Risk factors for visual impairment associated with corneal diseases in southern China. Clinical Ophthalmology 2016, Volume 10: 777-782. PMID: 27194904, PMCID: PMC4859424, DOI: 10.2147/opth.s103302.Peer-Reviewed Original ResearchInfectious keratitisCorneal diseaseRisk factorsVisual impairmentRural residenceTraditional Chinese medicineVisual outcomeConsecutive patientsMale sexOdds ratioOlder ageChinese medicineWorld Health Organization recommendationsWorse visual outcomeDry eye syndromeSignificant risk factorsSecond Xiangya HospitalCross-sectional studyLogistic regression modelsCentral South UniversityBinary logistic regression modelCorneal abrasionCornea clinicNoninfectious etiologiesOcular trauma